» Articles » PMID: 9682365

Immune Induction and Modulation by Topical Ocular Administration of Plasmid DNA Encoding Antigens and Cytokines

Overview
Journal Vaccine
Date 1998 Jul 31
PMID 9682365
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

In this article, the authors investigated if administration of eukaryotic expression plasmid DNA delivered to the ocular surface provided a means of inducing and modulating the immune response to herpes simplex virus (HSV). Topical application of gB DNA led to the development of HSV specific systemic humoral and cellular immunity. In addition, mucosal antibody was induced at both proximal and distal locations. Topically gB DNA immunized animals were protected against lethal challenge via either the systemic or the vaginal mucosal routes. Ocular pre-exposure to DNA encoding the cytokines interleukin (IL)-4 or IL-10, but not IL-2 or interferon-gamma, modulated the severity of the immunoinflammatory response to subsequent corneal infection with HSV. The present results indicate that the ocular surface provides a readily accessible site for DNA immunization and is suitable for both immune induction and modulation of the nature of the immune response that is induced.

Citing Articles

Gene Therapy in the Anterior Eye Segment.

Amador C, Shah R, Ghiam S, Kramerov A, Ljubimov A Curr Gene Ther. 2021; 22(2):104-131.

PMID: 33902406 PMC: 8531184. DOI: 10.2174/1566523221666210423084233.


Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures.

Tesoro-Cruz E, Oviedo N, Manuel-Apolinar L, Orozco-Suarez S, Perez de la Mora M, Martinez-Perez G Mol Biotechnol. 2020; 62(3):200-209.

PMID: 32030628 DOI: 10.1007/s12033-020-00239-x.


Targeting herpetic keratitis by gene therapy.

Elbadawy H, Gailledrat M, Desseaux C, Ponzin D, Ferrari S J Ophthalmol. 2013; 2012:594869.

PMID: 23326647 PMC: 3541562. DOI: 10.1155/2012/594869.


Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.

Heiligenhaus A, Li H, Schmitz A, Wasmuth S, Bauer D Clin Exp Immunol. 2005; 142(1):180-7.

PMID: 16178874 PMC: 1809498. DOI: 10.1111/j.1365-2249.2005.02896.x.


Mucosal immunity: overcoming the barrier for induction of proximal responses.

McKenzie B, Brady J, Lew A Immunol Res. 2004; 30(1):35-71.

PMID: 15258310 DOI: 10.1385/IR:30:1:035.